Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-09-28

Clinical Trial Update: Randomized Study of PH-10 for Psoriasis [Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 2 randomized study of PH-10 for psoriasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PH-10

Snippet

Sponsor: Provectus Pharmaceuticals | Conditions: Psoriasis | Phase 2 | Status: COMPLETED